RedFuMOS: A novel approach for multi-omics and clinical data-driven patient stratification
- 1University of Turin
Abstract
BackgroundPatient stratification from multi-omics and clinical data is essential for uncovering disease heterogeneity and moving toward more personalized treatment strategies. However, integrating heterogeneous data layers while identifying robust patient strata remains challenging.
MethodsWe introduce Reduced Fusion of Multi-Omics Stratification (RedFuMOS), a novel three-step approach for patient stratification based on mixed-type multi-omics data. RedFuMOS extends Similarity Network Fusion to accommodate mixed-type data layers and layer-specific similarity measures for data integration, includes a dimensionality reduction step to mitigate the curse of dimensionality, and performs patient stratification using density-based hierarchical clustering with HDBSCAN. It also implemented an automated optimization procedure to identify the best set of hyperparameters, minimizing the need for manual tuning.
ResultsRedFuMOS outperformed six state-of-the-art tools for multi-omics patient stratification in a comprehensive simulated benchmarking study, which also confirmed that, although computationally expensive, the dimensionality reduction step is crucial for achieving good stratification performance. Additionally, RedFuMOS identified two clinically relevant patient strata in a small real-world cohort of patients with Philadelphia chromosome-positive chronic myeloid leukaemia.
ConclusionRedFuMOS provides a flexible framework for integrating heterogeneous multi-omics and clinical data. RedFuMOS is available as an R package at http://github.com/delucasara/RedFuMOS.
Related
- Plasma proteomic signatures in bipolar disorder and their implications for data-driven patient stratification
- Risk stratification for MDR/RR-TB: a comprehensive integrated patient-level analysis from TB programs and contemporary clinical trials.
- Extracellular vesicles in vascular cognitive impairment and dementia: a neurovascular evidence map for patient stratification and clinical translation
- Stage-driven mortality and clinical risk stratification among lung cancer patients in Dhaka, Bangladesh: A multi-hospital secondary analysis
- An interpretable cell-centric representation of pancreatic ductal adenocarcinoma matches multiple-instance learning for clinical outcomes and leads to novel pathologist-driven histological biomarkers
BibTeX
@misc{luca2026redfumos,
title = {{RedFuMOS: A novel approach for multi-omics and clinical data-driven patient stratification}},
author = {S. De Luca and C. Fava and G. Rizzo and A. Visconti and P. Berchialla},
howpublished = {medRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.26.26361415},
url = {https://www.medrxiv.org/content/10.64898/2026.08.26.26361415v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - RedFuMOS: A novel approach for multi-omics and clinical data-driven patient stratification
AU - S. De Luca
AU - C. Fava
AU - G. Rizzo
AU - A. Visconti
AU - P. Berchialla
PY - 2026
DA - 2026/08/26
PB - medRxiv
DO - 10.64898/2026.08.26.26361415
UR - https://www.medrxiv.org/content/10.64898/2026.08.26.26361415v1
AB - BackgroundPatient stratification from multi-omics and clinical data is essential for uncovering disease heterogeneity and moving toward more personalized treatment strategies. However, integrating heterogeneous data layers while identifying robust patient strata remains challenging. MethodsWe introduce Reduced Fusion of Multi-Omics Stratification (RedFuMOS), a novel three-step approach for patient stratification based on mixed-type multi-omics data. RedFuMOS extends Similarity Network Fusion to accommodate mixed-type data layers and layer-specific similarity measures for data integration, includes a dimensionality reduction step to mitigate the curse of dimensionality, and performs patient stratification using density-based hierarchical clustering with HDBSCAN. It also implemented an automated optimization procedure to identify the best set of hyperparameters, minimizing the need for manual tuning. ResultsRedFuMOS outperformed six state-of-the-art tools for multi-omics patient stratification in a comprehensive simulated benchmarking study, which also confirmed that, although computationally expensive, the dimensionality reduction step is crucial for achieving good stratification performance. Additionally, RedFuMOS identified two clinically relevant patient strata in a small real-world cohort of patients with Philadelphia chromosome-positive chronic myeloid leukaemia. ConclusionRedFuMOS provides a flexible framework for integrating heterogeneous multi-omics and clinical data. RedFuMOS is available as an R package at http://github.com/delucasara/RedFuMOS.
ER -